Does size matter?: Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell Therapy : acute myeloid leukemia
We investigated the effect of center-specific variables on overall survival (OS) after allogeneic hematopoietic cell transplantation (alloHCT) in acute myeloid leukemia (AML). Eligible for the study were adult patients reported to the German Registry for Hematopoietic Stem Cell Transplantation and C...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
June 2025
|
| In: |
Haematologica
Year: 2025, Jahrgang: 110, Heft: 6, Pages: 1292-1303 |
| ISSN: | 1592-8721 |
| DOI: | 10.3324/haematol.2024.286385 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.3324/haematol.2024.286385 Verlag, kostenfrei, Volltext: https://haematologica.org/article/view/11863 
|
| Verfasserangaben: | Wolfgang Bethge, Sarah Flossdorf, Franziska Hanke, Christoph Schmid, Mark Ringhoffer, Stefan Klein, Bernd Hertenstein, Johannes Schetelig, Matthias Stelljes, Thomas Schroeder, Igor Wolfgang Blau, Francis Ayuk, Matthias Eder, Robert Zeiser, Katharina Fleischhauer, Nicolaus Kröger and Peter Dreger; on behalf of the German Working Group for Hematopoietic Stem Cell Transplantation and Cellular Therapy e.V. (DAG-HSZT)and the German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy (DRST) |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1936753758 | ||
| 003 | DE-627 | ||
| 005 | 20251023215741.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250925s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3324/haematol.2024.286385 |2 doi | |
| 035 | |a (DE-627)1936753758 | ||
| 035 | |a (DE-599)KXP1936753758 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Bethge, Wolfgang Andreas |d 1967- |e VerfasserIn |0 (DE-588)114961050 |0 (DE-627)587792981 |0 (DE-576)176468978 |4 aut | |
| 245 | 1 | 0 | |a Does size matter? |b Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell Therapy : acute myeloid leukemia |c Wolfgang Bethge, Sarah Flossdorf, Franziska Hanke, Christoph Schmid, Mark Ringhoffer, Stefan Klein, Bernd Hertenstein, Johannes Schetelig, Matthias Stelljes, Thomas Schroeder, Igor Wolfgang Blau, Francis Ayuk, Matthias Eder, Robert Zeiser, Katharina Fleischhauer, Nicolaus Kröger and Peter Dreger; on behalf of the German Working Group for Hematopoietic Stem Cell Transplantation and Cellular Therapy e.V. (DAG-HSZT)and the German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy (DRST) |
| 264 | 1 | |c June 2025 | |
| 300 | |b Diagramme | ||
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 25.09.2025 | ||
| 520 | |a We investigated the effect of center-specific variables on overall survival (OS) after allogeneic hematopoietic cell transplantation (alloHCT) in acute myeloid leukemia (AML). Eligible for the study were adult patients reported to the German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy (DRST) receiving first alloHCT for AML from a related or matched (>9/10 HLA-match) unrelated donor in the period 2015-2021. Primary endpoint was OS at 12 months from alloHCT. Univariable and multivariable analyses after best subset selection were performed. Of 5,328 patients, 83% received alloHCT in a high-volume center (≥40 alloHCT/year), 90% in a university hospital, 90% in a center performing alloHCT for ≥10 years, and 73% in a Joint Accreditation Committee ISCT-Europe & European Group for Blood and Marrow Transplantation (EBMT) (JACIE) accredited center. 52% of the patients were in first CR, and European LeukemiaNet risk was adverse in 37% and intermediate in 42%. On multivariable analysis, center-specific factors predicting adverse 12-month OS were program duration <5-10 years (Hazard Ratio [HR] 1.23, [95% Confidence Interval: [1.02; 1.49]), center volume <40 alloHCT/year (HR 1.21, [1.02; 1.45]), and treatment at a non-university hospital (HR 1.21, [0.98; 1.49]), whereas JACIE accreditation did not. Spline modeling suggested a negative effect of a center volume up to 45 alloHCT per year. Center volume, center experience, university hospital, but not JACIE accreditation, have an impact on alloHCT outcomes in adult patients with AML in Germany. | ||
| 700 | 1 | |a Flossdorf, Sarah |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hanke, Franziska |e VerfasserIn |4 aut | |
| 700 | 1 | |8 1\p |a Schmid, Christoph |e VerfasserIn |0 (DE-588)1176729551 |0 (DE-627)1047755327 |0 (DE-576)516777637 |4 aut | |
| 700 | 1 | |a Ringhoffer, Mark |e VerfasserIn |4 aut | |
| 700 | 1 | |a Klein, Stefan |e VerfasserIn |0 (DE-588)1042491836 |0 (DE-627)769066372 |0 (DE-576)393988791 |4 aut | |
| 700 | 1 | |a Hertenstein, Bernd |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schetelig, Johannes |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stelljes, Matthias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schroeder, Thomas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Blau, Igor Wolfgang |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ayuk, Francis |e VerfasserIn |4 aut | |
| 700 | 1 | |a Eder, Matthias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zeiser, Robert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fleischhauer, Katharina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kröger, Nicolaus |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dreger, Peter |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Haematologica |d Pavia : Ferrata Storti Foundation, 2014 |g 110(2025), 6 vom: Juni, Seite 1292-1303 |h Online-Ressource |w (DE-627)814204899 |w (DE-600)2805244-4 |w (DE-576)424051125 |x 1592-8721 |7 nnas |a Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell Therapy : acute myeloid leukemia |
| 773 | 1 | 8 | |g volume:110 |g year:2025 |g number:6 |g month:06 |g pages:1292-1303 |g extent:12 |a Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell Therapy : acute myeloid leukemia |
| 856 | 4 | 0 | |u https://doi.org/10.3324/haematol.2024.286385 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://haematologica.org/article/view/11863 |x Verlag |z kostenfrei |3 Volltext |
| 883 | |8 1\p |a cgwrk |d 20251001 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 951 | |a AR | ||
| 992 | |a 20250925 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 1042491836 |a Klein, Stefan |m 1042491836:Klein, Stefan |d 60000 |e 60000PK1042491836 |k 0/60000/ |p 6 | ||
| 999 | |a KXP-PPN1936753758 |e 4775885677 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title_sort":"Does size matter?","subtitle":"Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell Therapy : acute myeloid leukemia","title":"Does size matter?"}],"relHost":[{"origin":[{"publisherPlace":"Pavia","dateIssuedKey":"2014","publisher":"Ferrata Storti Foundation","dateIssuedDisp":"2014-"}],"recId":"814204899","titleAlt":[{"title":"journal of the European Hematology Association"}],"pubHistory":["99.2014 -"],"part":{"extent":"12","year":"2025","volume":"110","text":"110(2025), 6 vom: Juni, Seite 1292-1303","pages":"1292-1303","issue":"6"},"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"eki":["814204899"],"zdb":["2805244-4"],"issn":["1592-8721"]},"disp":"Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell Therapy : acute myeloid leukemiaHaematologica","note":["Gesehen am 27.05.2022"],"title":[{"title_sort":"Haematologica","title":"Haematologica","subtitle":"journal of the European Hematology Association : journal of the Ferrata Storti Foundation"}],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"]}],"physDesc":[{"extent":"12 S.","noteIll":"Diagramme"}],"id":{"doi":["10.3324/haematol.2024.286385"],"eki":["1936753758"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"person":[{"given":"Wolfgang Andreas","family":"Bethge","role":"aut","display":"Bethge, Wolfgang Andreas"},{"family":"Flossdorf","given":"Sarah","display":"Flossdorf, Sarah","role":"aut"},{"role":"aut","display":"Hanke, Franziska","given":"Franziska","family":"Hanke"},{"family":"Schmid","given":"Christoph","display":"Schmid, Christoph","role":"aut"},{"family":"Ringhoffer","given":"Mark","display":"Ringhoffer, Mark","role":"aut"},{"given":"Stefan","family":"Klein","role":"aut","display":"Klein, Stefan"},{"family":"Hertenstein","given":"Bernd","display":"Hertenstein, Bernd","role":"aut"},{"family":"Schetelig","given":"Johannes","display":"Schetelig, Johannes","role":"aut"},{"family":"Stelljes","given":"Matthias","display":"Stelljes, Matthias","role":"aut"},{"role":"aut","display":"Schroeder, Thomas","given":"Thomas","family":"Schroeder"},{"display":"Blau, Igor Wolfgang","role":"aut","family":"Blau","given":"Igor Wolfgang"},{"family":"Ayuk","given":"Francis","display":"Ayuk, Francis","role":"aut"},{"family":"Eder","given":"Matthias","display":"Eder, Matthias","role":"aut"},{"display":"Zeiser, Robert","role":"aut","family":"Zeiser","given":"Robert"},{"role":"aut","display":"Fleischhauer, Katharina","given":"Katharina","family":"Fleischhauer"},{"given":"Nicolaus","family":"Kröger","role":"aut","display":"Kröger, Nicolaus"},{"display":"Dreger, Peter","role":"aut","family":"Dreger","given":"Peter"}],"origin":[{"dateIssuedDisp":"June 2025","dateIssuedKey":"2025"}],"note":["Gesehen am 25.09.2025"],"recId":"1936753758","name":{"displayForm":["Wolfgang Bethge, Sarah Flossdorf, Franziska Hanke, Christoph Schmid, Mark Ringhoffer, Stefan Klein, Bernd Hertenstein, Johannes Schetelig, Matthias Stelljes, Thomas Schroeder, Igor Wolfgang Blau, Francis Ayuk, Matthias Eder, Robert Zeiser, Katharina Fleischhauer, Nicolaus Kröger and Peter Dreger; on behalf of the German Working Group for Hematopoietic Stem Cell Transplantation and Cellular Therapy e.V. (DAG-HSZT)and the German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy (DRST)"]}} | ||
| SRT | |a BETHGEWOLFDOESSIZEMA2025 | ||